Nothing Special   »   [go: up one dir, main page]

PE20200608A1 - Nuevos derivados de azaquinolina - Google Patents

Nuevos derivados de azaquinolina

Info

Publication number
PE20200608A1
PE20200608A1 PE2019002610A PE2019002610A PE20200608A1 PE 20200608 A1 PE20200608 A1 PE 20200608A1 PE 2019002610 A PE2019002610 A PE 2019002610A PE 2019002610 A PE2019002610 A PE 2019002610A PE 20200608 A1 PE20200608 A1 PE 20200608A1
Authority
PE
Peru
Prior art keywords
hydrogen
trifluorophenyl
naphthyridine
morpholin
carboxamide
Prior art date
Application number
PE2019002610A
Other languages
English (en)
Inventor
Nils Griebenow
Wei Zhuang
Adeline Kohler
Daniel Kulke
Claudia Bohm
Kirsten Borngen
Thomas Ilg
Hans-Georg Schwarz
Werner Hallenbach
Ulrich Gorgens
Walter Hubsch
Bernd Alig
Iring Heisler
Isa Jana Irina Janssen
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of PE20200608A1 publication Critical patent/PE20200608A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se refiere a compuestos derivados de azaquinolona de la formula general (I), donde A es A1 o A2; o es 0, 1, 2, 3 o 4; R es hidrogeno, halogeno, entre otros; X e Y se seleccionan independientemente del grupo que consiste en CR7R8, O, S y N-R9; o forman conjuntamente un miembro del anillo seleccionado del grupo que consiste en -C(O)-O-, -C(O)-NR9-, entre otros; T se selecciona de T1- T6; R1 es hidrogeno, ciano, -CHO, entre otros; R10 es hidrogeno, -OH, alquilo-C1-C4 y alcoxi-C1-C4; R11 es hidrogeno, alquilo-C1-C4 y alcoxi-C1-C4; o R10 y R11 forman, junto con el carbono al que estan unidos, un anillo de 3 a 6 miembros. Son compuestos preferidos: N-[(4S)-3,4-dihidro-2H-1-benzopiran-4-il]-4-(morfolin-4-il)-8-(2,3,5-trifluorofenil)-1,7-naftiridina-3-carboxamida; N-[(4S)-3,4-dihidro-2H-cromen-4-il]-4-(morfolin-4-il)-8-(2,3,5-trifluorofenil)-1,7-naftiridina-3-carboxamida, entre otros. Dichos compuestos interactuan eficazmente con los Slo-1 de los nematodos logrando su paralisis e inhibicion, siendo util en el tratamiento o prevencion de infecciones por helmintos gastrointestinales y extraintestinales. Tambien se refiere a una composicion farmaceutica que comprende dicho compuesto.
PE2019002610A 2017-06-30 2018-06-22 Nuevos derivados de azaquinolina PE20200608A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17179149 2017-06-30
PCT/EP2018/066776 WO2019002132A1 (en) 2017-06-30 2018-06-22 NEW AZAQUINOLINE DERIVATIVES

Publications (1)

Publication Number Publication Date
PE20200608A1 true PE20200608A1 (es) 2020-03-10

Family

ID=59269946

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2019002610A PE20200608A1 (es) 2017-06-30 2018-06-22 Nuevos derivados de azaquinolina

Country Status (23)

Country Link
US (1) US11485733B2 (es)
EP (1) EP3615527B1 (es)
JP (1) JP7210483B2 (es)
KR (1) KR20200020911A (es)
CN (1) CN110770227B (es)
AR (1) AR112216A1 (es)
AU (1) AU2018293627B2 (es)
BR (1) BR112019028181A2 (es)
CA (1) CA3068350A1 (es)
CL (1) CL2019003892A1 (es)
CO (1) CO2019014484A2 (es)
CR (1) CR20190595A (es)
DK (1) DK3615527T3 (es)
ES (1) ES2984497T3 (es)
IL (1) IL271607B2 (es)
MX (1) MX2019015895A (es)
PE (1) PE20200608A1 (es)
PH (1) PH12019502851A1 (es)
PL (1) PL3615527T3 (es)
TW (1) TWI799429B (es)
UA (1) UA125800C2 (es)
UY (1) UY37789A (es)
WO (1) WO2019002132A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3106092A1 (en) * 2018-07-09 2020-01-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelminthic heterocyclic compounds
AR116908A1 (es) 2018-12-18 2021-06-23 Elanco Tiergesundheit Ag Derivados bicíclicos
AR116909A1 (es) 2018-12-18 2021-06-23 Elanco Tiergesundheit Ag Derivados bicíclicos
CN119285648A (zh) * 2019-03-19 2025-01-10 勃林格殷格翰动物保健有限公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
AU2020289459A1 (en) 2019-06-07 2022-01-06 Elanco Tiergesundheit Ag Bicyclic derivatives for treating endoparasites
JP2022542682A (ja) * 2019-07-30 2022-10-06 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング イソキノリン誘導体および寄生虫感染の治療のためのそれらの使用
WO2021204930A1 (en) 2020-04-09 2021-10-14 Bayer Animal Health Gmbh Substituted condensed azines as anthelmintic compounds
CA3183100A1 (en) 2020-05-29 2021-12-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelmintic heterocyclic compounds
WO2022106469A2 (en) 2020-11-18 2022-05-27 Elanco Tiergesundheit Ag N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
TW202237600A (zh) 2020-12-04 2022-10-01 瑞士商禮藍動物保健股份有限公司 雙環衍生物
EP4148052A1 (en) * 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
CN118339164A (zh) 2021-11-01 2024-07-12 勃林格殷格翰动物保健有限公司 驱虫吡咯并哒嗪化合物
WO2024213752A1 (en) 2023-04-14 2024-10-17 Elanco Animal Health Gmbh Long-term prevention and/or treatment of a disease by slo-1 inhibitors
WO2025027117A1 (en) 2023-08-02 2025-02-06 Intervet International B.V. Carboxamide-4-quinoline compounds with anthelmintic activity

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479955A (en) 1983-01-10 1984-10-30 Ciba-Geigy Corporation Heterocycle-fused pyrazolo[3,4-d]pyridin-3-ones as benzodiazepine receptor modulators
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
KR0169813B1 (ko) 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
WO1998035967A2 (en) 1997-02-18 1998-08-20 Neurocrine Biosciences, Inc. Biazacyclic crf antagonists
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
MXPA02007289A (es) * 2000-01-28 2003-09-22 Melacure Therapeutics Ab Agonistas y antagonistas novedosos de receptores de melanocortina.
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
SE0202461D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
KR101310073B1 (ko) 2004-10-20 2013-09-24 이하라케미칼 고교가부시키가이샤 3-트리아졸릴페닐설파이드 유도체 및 그것을유효성분으로서 함유하는 살충·살진드기·살선충제
CA2589221A1 (en) * 2005-01-28 2006-08-03 Janssen Pharmaceutica N.V. Anthelmintic imidazol-thiazole derivates
US7304074B2 (en) 2005-04-05 2007-12-04 Hoffmann-La Roche Inc. Substituted 1,5-naphthyridine azolinones
CA2608072A1 (en) 2005-05-24 2006-11-30 Astrazeneca Ab Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
US7938851B2 (en) 2005-06-08 2011-05-10 Xtent, Inc. Devices and methods for operating and controlling interventional apparatus
PT1947098E (pt) 2005-10-06 2012-01-12 Nippon Soda Co Compostos de amina cíclicos e agente para controlo de pragas
US7465795B2 (en) * 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
KR20080080206A (ko) 2005-12-20 2008-09-02 아스트라제네카 아베 Ｇａｂａａ-수용체 조절제로서의 치환된 신놀린 유도체 및그의 합성 방법
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
NZ598890A (en) 2007-04-30 2013-10-25 Genentech Inc Inhibitors of iap
BRPI0812369A2 (pt) 2007-06-08 2016-08-09 Helicon Therapeutics Inc composto e composição farmacêutica e métodos de modulação de um ou mais subtipos de gabaa e de tratamento de deficiência orgânica cognitiva, de desordem psiquiátrica e de de aumento da função congnitiva em animal e usos de composto ou de composição farmacêutica.
WO2009036412A1 (en) 2007-09-14 2009-03-19 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
EP2231665A4 (en) 2008-01-07 2012-04-25 Ardea Biosciences Inc NEW COMPOSITIONS AND METHODS OF USE
MX2010009755A (es) 2008-03-11 2010-09-30 Neurosearch As Nuevos derivados de triarilo utiles como moduladores de receptores de acetilcolina nicotinicos.
JP5268461B2 (ja) 2008-07-14 2013-08-21 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337940B (zh) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101337937B (zh) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
EP2370436A1 (en) * 2008-11-13 2011-10-05 Link Medicine Corporation Azaquinolinone derivatives and uses thereof
TWI466634B (zh) 2008-12-12 2015-01-01 Syngenta Participations Ag 化合物
WO2011085575A1 (zh) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
CN102199152A (zh) 2010-03-25 2011-09-28 高大新 杂环咪唑类磷脂激酶抑制剂
WO2011151146A1 (en) 2010-05-31 2011-12-08 Syngenta Participations Ag Method of crop enhancement
CR20200540A (es) 2010-08-31 2021-03-16 Meiji Seika Pharma Co Ltd DERIVADOS DE AMINA PARA EL CONTROL DE PLAGAS (Divisional 2019-0244)
CN101967139B (zh) 2010-09-14 2013-06-05 中化蓝天集团有限公司 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用
WO2012112363A1 (en) 2011-02-14 2012-08-23 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
BR112013030095A2 (pt) 2011-05-23 2019-09-24 Elan Pharm Inc inibidores de atividade de lrrk2 cinase
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
JP2015502936A (ja) * 2011-11-28 2015-01-29 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ スルホンアミド駆虫薬
TWI566701B (zh) 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
CA2863892C (en) 2012-03-06 2016-08-30 Pfizer Inc. Macrocyclic derivatives for the treatment of proliferative diseases
WO2013148603A1 (en) 2012-03-27 2013-10-03 Takeda Pharmaceutical Company Limited Cinnoline derivatives as as btk inhibitors
JP2015512907A (ja) 2012-03-30 2015-04-30 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 有害動物を駆除するためのｎ−置換ピリジニリデン化合物および誘導体
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
RU2627654C2 (ru) 2012-04-27 2017-08-09 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Пестицидные композиции и относящиеся к ним способы
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
CN103232431B (zh) 2013-01-25 2014-11-05 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
CN103109816B (zh) 2013-01-25 2014-09-10 青岛科技大学 硫代苯甲酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
US8957078B2 (en) 2013-03-15 2015-02-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US20140336182A1 (en) 2013-05-13 2014-11-13 Amgen Inc. Aurora Kinase Modulators and Method of Use
US20160081342A1 (en) 2013-05-23 2016-03-24 Syngenta Participations Ag Tank-mix formulations
CN103265527B (zh) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
TWI529171B (zh) 2013-07-29 2016-04-11 赫孚孟拉羅股份公司 １，７－萘啶衍生物
CN103524422B (zh) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
CA2925873A1 (en) 2013-10-17 2015-04-23 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
EP3057430A4 (en) 2013-10-17 2017-09-13 Dow AgroSciences LLC Processes for the preparation of pesticidal compounds
CN105873914B (zh) * 2013-10-23 2018-10-19 拜耳作物科学股份公司 作为害虫防治剂的取代的喹喔啉衍生物
US9452986B2 (en) * 2014-02-06 2016-09-27 Abbvie Inc. 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
RU2695815C9 (ru) 2014-03-24 2019-10-28 Гуандун Чжуншэн Фармасьютикал Ко., Лтд Хинолиновые производные в качестве ингибиторов smo
TWI649307B (zh) 2014-05-07 2019-02-01 日商橘生藥品工業股份有限公司 Cyclohexylpyridine derivative
TW201613866A (en) 2014-07-07 2016-04-16 Bayer Cropscience Ag Process for preparing fluorinated iminopyridine compounds
UY36196A (es) * 2014-07-25 2016-02-29 Bayer Animal Health Gmbh Compuestos para usar en el tratamiento antihelmíntico
CN107205396B (zh) 2015-02-17 2019-08-30 日本曹达株式会社 农药组合物
WO2016196961A1 (en) 2015-06-03 2016-12-08 Uwm Research Foundation, Inc. Ligands selective to alpha 6 subunit-containing gabaa receptors ans their methods of use
CA3043298A1 (en) 2016-11-11 2018-05-17 Bayer Animal Health Gmbh Anthelmintic quinoline-3-carboxamide derivatives

Also Published As

Publication number Publication date
AU2018293627B2 (en) 2022-07-21
CN110770227B (zh) 2024-03-01
IL271607B1 (en) 2023-03-01
NZ759633A (en) 2024-05-31
ES2984497T3 (es) 2024-10-29
IL271607A (en) 2020-02-27
UA125800C2 (uk) 2022-06-08
PH12019502851A1 (en) 2020-10-19
MX2019015895A (es) 2020-02-07
CL2019003892A1 (es) 2020-07-10
CR20190595A (es) 2020-03-03
AU2018293627A1 (en) 2019-12-12
CN110770227A (zh) 2020-02-07
BR112019028181A2 (pt) 2020-07-07
RU2020103733A3 (es) 2021-10-22
RU2020103733A (ru) 2021-07-30
UY37789A (es) 2019-01-31
JP7210483B2 (ja) 2023-01-23
CA3068350A1 (en) 2019-01-03
US20200131175A1 (en) 2020-04-30
EP3615527B1 (en) 2024-03-06
DK3615527T3 (da) 2024-05-06
KR20200020911A (ko) 2020-02-26
IL271607B2 (en) 2023-07-01
JP2020525444A (ja) 2020-08-27
TW201904961A (zh) 2019-02-01
EP3615527A1 (en) 2020-03-04
PL3615527T3 (pl) 2024-07-01
CO2019014484A2 (es) 2020-01-17
US11485733B2 (en) 2022-11-01
TWI799429B (zh) 2023-04-21
WO2019002132A1 (en) 2019-01-03
AR112216A1 (es) 2019-10-02

Similar Documents

Publication Publication Date Title
PE20200608A1 (es) Nuevos derivados de azaquinolina
CR9690A (es) 3-acilaminobenzanilidas insecticidas
PE20220597A1 (es) Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos
PE20190118A1 (es) Eliminacion del virus de la hepatitis b con agentes antivirales
PE20160608A1 (es) Compuestos de quinolina selectivamente sustituida
PE20170247A1 (es) Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1
CL2016002942A1 (es) Nuevos derivados de pirazolina pirimidina y su uso como inhibidores de malt1
PE20211472A1 (es) Derivados de 2-(feniloxi o feniltio)pirimidina como herbicidas
PE20191020A1 (es) Compuestos quimicos
CO6251271A2 (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
AR072166A1 (es) Derivado de piperidina y su uso como inhibidor de renina superior
AR053739A1 (es) Compuestos espiro condensados como inhibidores de la aldosterona sintasa
AR058719A1 (es) Derivados de isoxazol-4-il-oxadiazol
AR061369A1 (es) Derivados de pirimidina y composiciones farmaceuticas que los comprenden
PE20170323A1 (es) Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble
DOP2007000079A (es) Compuestos fenil amido heterocíclicos condensados
PE20200604A1 (es) Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue
ES2567311T3 (es) 6-(3-Aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas como antagonistas del receptor de ADP
PE20190968A1 (es) Compuestos de heterociclo tetraciclicos utiles como inhibidores de la integrasa del vih
PE20140703A1 (es) Derivados de heteroarilo como moduladores de nachr alfa 7
NI201000011A (es) Derivados de pirimidina 934.
AR048362A1 (es) Derivados de tetrahidronaftiridina y proceso para la preparacion de los mismos
PE20170501A1 (es) Un procedimiento que comprende compuestos que administran a un sujeto infectado con neisseria gonorrhoeae
PE20140792A1 (es) Composiciones farmaceuticas
PE20190964A1 (es) Inhibidores de dopamina-b-hidroxilasa penetrantes de la barrera hematoencefalica